How can probiotic targeted release tablets enhance probiotic cell membrane stability and reduce bacterial inactivation in a high-bile digestive environment?
Publish Time: 2026-05-25
In the fields of gut microbiota regulation, digestive function improvement, and immune health management, probiotic targeted release tablets are widely used in the combined treatment of various intestinal problems due to their targeted release, resistance to gastric acid, and high live bacteria delivery capabilities. Especially during human digestion, probiotics need to pass through multiple complex environments, including gastric acid, digestive enzymes, and high-concentration bile. Bile, with its strong alkalinity and surface activity, easily damages the probiotic cell membrane structure, leading to bacterial inactivation. If probiotics cannot successfully pass through bile-secreting areas such as the duodenum, it not only reduces the number of live bacteria colonizing but also weakens the subsequent intestinal regulatory effects.1. Optimizing strain selection to enhance natural bile resistanceThe bile resistance of probiotics is a crucial basis for their survival rate. If the strain's cell membrane structure is weak, membrane protein denaturation and leakage of cell contents are likely to occur after entering a bile environment. Therefore, many probiotic targeted release tablets now prioritize the screening of strains with high bile salt tolerance, such as certain lactobacillus and bifidobacteria varieties. These strains have more stable cell membrane fatty acid compositions, enabling them to maintain normal metabolic function in high-bile environments. Simultaneously, some companies utilize strain domestication and cultivation techniques to gradually adapt probiotics to high-bile salt environments, thereby enhancing their cell membrane resistance to damage. Optimizing the source of strains not only improves the survival ability of probiotics in the digestive tract but also enhances subsequent intestinal colonization efficiency.2. Using Multi-Layer Coating Technology to Reduce Direct Bile DamageBile salts in bile have strong surface activity and can easily directly damage the cell membrane structure of probiotics. Therefore, coating protection technology has become an important way to improve the survival rate of live bacteria. Currently, high-performance probiotic targeted release tablets typically employ a multi-layer sustained-release coating structure. Hydrophobic materials form a protective barrier on the tablet surface, reducing direct contact between bile and probiotics. Furthermore, some coating materials also possess pH-responsive properties, maintaining stability in the stomach and gradually dissolving in specific intestinal regions for precise release. Compared to traditional tablets, multi-layer coating not only slows down bile salt penetration but also prolongs the protection time of probiotics, thereby reducing the problem of significant bacterial inactivation in the duodenum.3. Enhanced Cell Membrane Nutritional Protection and Improved Stress ResistanceBesides external coating protection, the stability of the probiotic cell membrane itself is also crucial. Therefore, more and more products are incorporating phospholipids, polysaccharides, and antioxidants into their formulations to enhance the resilience of probiotic cell membranes. Polysaccharides can form a protective layer on the bacterial surface, reducing direct erosion of the cell membrane by bile, while antioxidants help reduce oxidative damage caused by bile salts. Simultaneously, some nutrients can promote the metabolic activity of probiotics, improving their self-repair ability under adversity. Through synergistic nutritional protection, not only is the bile resistance of probiotics enhanced, but their activity and reproductive capacity after entering the intestines are also improved.4. Optimized Release Pathway and Improved Intestinal Colonization EfficiencyIf probiotics remain in the peak bile secretion region for too long, the risk of bacterial inactivation will also increase. Therefore, modern probiotic targeted release tablets employ precise targeting release technology, controlling disintegration time and release rate to allow probiotics to rapidly pass through high-cholesterol regions and be released concentratedly in the small or colon. Simultaneously, some products incorporate sustained-release microcapsule structures to enhance the sustained release of probiotics in the target intestinal region, thereby strengthening colonization. By optimizing the release pathway, not only can the continuous damage to probiotics caused by the high-cholesterol environment be reduced, but the utilization rate of live bacteria and the effect of intestinal microecological regulation can also be improved.
